TP53 and diffuse large B-cell lymphoma: In the study conducted by Hong, et al.,45 the TP53 mutation was found in 386 (16%) of 2464 patients with DLBCL, and the TP53 mutation was significantly associated with the worse OS in patients with geminal center B‐cell (GCB) subtype or unclassified subtype but not in activated B‐cell (ABC) subtype.